O166 ALL-ORAL DUAL THERAPY WITH DACLATASVIR AND ASUNAPREVIR IN PATIENTS WITH HCV GENOTYPE 1B INFECTION: PHASE 3 STUDY RESULTS
M.P. Manns,
S. Pol,
Ira M. Jacobson,
Patrick Marcellin,
Stuart C. Gordon,
Cheng‐Yuan Peng,
T.-T. Chang,
Jeong Heo,
Guido Gerken,
Boris Yoffe,
Journal of Hepatology · 2014 · 20 citations · 0 references